Approved since 1999
For women undergoing controlled ovarian hyperstimulation
Sterilized and ready to use, with no reconstitution needed
Stored at room temperature: 25 °C
(77 °F), with no refrigeration required
Maximum serum concentrations reached in about 1 hour
Available with a rigid needle shield not made with natural rubber latex
aDuring COH utilizing GnRH antagonist protocol for inhibition of premature LH surge.
COH=controlled ovarian hyperstimulation; GnRH=gonadotropin-releasing hormone; LH=luteinizing hormone.
Ganirelix Acetate Injection is indicated for the inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation.
Before prescribing Ganirelix Acetate Injection, please read the Prescribing Information.